🎁 Black Friday: up to 50% off of annual plans
Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,977.00
-103.00 (-4.95%)
At close: Nov 20, 2026

Green Lifescience Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,57613,4079,0686,3482,8143,388
Short-Term Investments
58.1225.46127.565,6692,3007,800
Trading Asset Securities
4,8403,7543,6902,43611,8355,015
Cash & Short-Term Investments
18,47417,18612,88514,45316,94916,203
Cash Growth
29.19%33.38%-10.85%-14.73%4.60%7.08%
Accounts Receivable
9,4376,8934,9971,4512,5093,450
Other Receivables
220.9935.9938.998.54333.75114.13
Receivables
9,6586,9295,0361,4602,8433,564
Inventory
8,7148,4183,9055,3116,0145,732
Prepaid Expenses
277.4749.4952.01160.1542.62735.77
Other Current Assets
73.9494.51112.3328.73595.04657.55
Total Current Assets
37,19732,67821,99121,71226,44326,892
Property, Plant & Equipment
17,16512,56013,53313,25627,11236,846
Long-Term Investments
-----7,381
Other Intangible Assets
409.2794.7497.472.8187.92181.72
Long-Term Deferred Tax Assets
-----619.37
Long-Term Deferred Charges
149.65170.6811.9224.91--
Other Long-Term Assets
7,9739,3619,3398,8338,78857.44
Total Assets
62,92554,86444,97243,82862,43271,977

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7,9347,6102,151--4,114
Accrued Expenses
854.7137.765.62--2.12
Short-Term Debt
6,8006,5004,8004,8006,4887,433
Current Portion of Leases
145.27124.1841.01104.04117.85104.86
Current Unearned Revenue
-26.146.723434-
Other Current Liabilities
1,6041,7131,2702,4552,7963,588
Total Current Liabilities
17,33816,0118,3147,3949,43715,242
Long-Term Leases
348.71367.99530.928.8218.2757.76
Pension & Post-Retirement Benefits
393.64146.95357.51443.95331.2371.39
Other Long-Term Liabilities
95.8450.3421.618.126.788.19
Total Liabilities
19,67616,5769,2247,8749,79315,679

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10,00010,00010,00010,0007,5007,500
Additional Paid-In Capital
15,84415,77715,02536,42538,95638,956
Retained Earnings
17,40412,87112,746-10,1056,2329,680
Treasury Stock
--360.3-2,023-366.29--
Comprehensive Income & Other
--0-00-48.7162.39
Shareholders' Equity
43,24938,28835,74835,95452,63956,298
Total Liabilities & Equity
62,92554,86444,97243,82862,43271,977

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
8,7946,9925,3724,9336,6247,595
Net Cash (Debt)
9,68010,1947,5139,52010,3248,608
Net Cash Growth
36.39%35.68%-21.08%-7.79%19.93%-1.28%
Net Cash Per Share
-531.08390.48476.93516.22430.42
Filing Date Shares Outstanding
-19.8419.0919.832020
Total Common Shares Outstanding
-19.8419.0919.832020
Working Capital
19,85916,66713,67714,31917,00711,651
Book Value Per Share
-1930.081872.831812.662631.952814.92
Tangible Book Value
42,83938,19335,65035,95152,55156,117
Tangible Book Value Per Share
-1925.301867.721812.522627.552805.83
Land
9,8408,4508,4508,4258,3297,923
Buildings
7,1297,0817,9187,84616,07713,381
Machinery
36,64935,86335,67735,43438,76639,913
Construction In Progress
3,199332.16-23.1207.0311,769